Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | LHX9 | Human | 1,2-dichloroethane | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of LHX9 mRNA | CTD | PMID:28960355 | LHX9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lhx9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LHX9 mRNA | CTD | PMID:24058054 | LHX9 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LHX9 mRNA | CTD | PMID:22298810 | LHX9 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of LHX9 mRNA | CTD | PMID:30616060 | LHX9 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol S affects the methylation of LHX9 gene | CTD | PMID:31683443 | LHX9 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of LHX9 mRNA | CTD | PMID:30951980 | LHX9 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of LHX9 mRNA | CTD | PMID:24780913 | LHX9 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of LHX9 mRNA | CTD | PMID:32763439 | LHX9 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of LHX9 gene | CTD | PMID:27153756 | LHX9 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of LHX9 exon and Aflatoxin B1 results in increased methylation of LHX9 intron | CTD | PMID:30157460 | LHX9 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of LHX9 mRNA | CTD | PMID:33167477 | LHX9 | Human | ammonium chloride | affects expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of LHX9 mRNA | CTD | PMID:16483693 | LHX9 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of LHX9 promoter | CTD | PMID:23974009 | LHX9 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of LHX9 intron and Benzo(a)pyrene affects the methylation of LHX9 promoter | CTD | PMID:27901495 and PMID:30157460 | LHX9 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of LHX9 5' UTR | CTD | PMID:27901495 | LHX9 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of LHX9 mRNA | CTD | PMID:28123099 | LHX9 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of LHX9 mRNA | CTD | PMID:31163220 | LHX9 | Human | bisphenol A | affects expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of LHX9 mRNA | CTD | PMID:25181051 | LHX9 | Human | bisphenol A | increases expression | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LHX9 mRNA | CTD | PMID:32156529 | LHX9 | Human | bisphenol A | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of LHX9 mRNA | CTD | PMID:30951980 | LHX9 | Human | bisphenol A | affects methylation | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol A affects the methylation of LHX9 promoter | CTD | PMID:27334623 | LHX9 | Human | bisphenol F | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of LHX9 mRNA | CTD | PMID:30951980 | LHX9 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of LHX9 mRNA | CTD | PMID:26079696 | LHX9 | Human | cadmium dichloride | affects expression | ISO | Lhx9 (Mus musculus) | 6480464 | Cadmium Chloride affects the expression of LHX9 mRNA | CTD | PMID:18974090 | LHX9 | Human | carbon nanotube | increases expression | ISO | Lhx9 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | LHX9 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LHX9 gene] | CTD | PMID:28238834 | LHX9 | Human | choline | multiple interactions | ISO | Lhx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX9 gene | CTD | PMID:20938992 | LHX9 | Human | dibutyl phthalate | decreases expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of LHX9 mRNA | CTD | PMID:21266533 | LHX9 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | LHX9 | Human | endosulfan | affects expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | Endosulfan affects the expression of LHX9 mRNA | CTD | PMID:29391264 | LHX9 | Human | folic acid | multiple interactions | ISO | Lhx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX9 gene | CTD | PMID:20938992 | LHX9 | Human | glyphosate | decreases expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | Glyphosate results in decreased expression of LHX9 mRNA | CTD | PMID:38314887 | LHX9 | Human | GW 4064 | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of LHX9 mRNA | CTD | PMID:26655953 | LHX9 | Human | L-methionine | multiple interactions | ISO | Lhx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX9 gene | CTD | PMID:20938992 | LHX9 | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of LHX9 mRNA | CTD | PMID:24810058 | LHX9 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Lhx9 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of LHX9 mRNA | CTD | PMID:28801915 | LHX9 | Human | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of LHX9 mRNA | CTD | PMID:26079696 | LHX9 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of LHX9 mRNA | CTD | PMID:26272509 | LHX9 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | LHX9 | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of LHX9 mRNA | CTD | PMID:29955902 | LHX9 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | LHX9 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of LHX9 mRNA | CTD | PMID:25895662 | LHX9 | Human | silver atom | affects expression | ISO | Lhx9 (Mus musculus) | 6480464 | Silver affects the expression of LHX9 mRNA | CTD | PMID:27131904 | LHX9 | Human | silver(0) | affects expression | ISO | Lhx9 (Mus musculus) | 6480464 | Silver affects the expression of LHX9 mRNA | CTD | PMID:27131904 | LHX9 | Human | tamoxifen | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of LHX9 mRNA | CTD | PMID:25123088 | LHX9 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | LHX9 | Human | triptonide | decreases expression | ISO | Lhx9 (Mus musculus) | 6480464 | triptonide results in decreased expression of LHX9 mRNA | CTD | PMID:33045310 | LHX9 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | LHX9 | Human | vanadyl sulfate | decreases expression | EXP | | 6480464 | vanadyl sulfate results in decreased expression of LHX9 mRNA | CTD | PMID:16330358 | LHX9 | Human | vinclozolin | increases methylation | ISO | Lhx9 (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of LHX9 gene | CTD | PMID:31079544 | LHX9 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of LHX9 mRNA | CTD | PMID:27188386 | |